Board Meeting7 Aug 2026, 07:31 pm
Aarey Drugs Board Meeting on Aug 14 to Approve Q1 FY27 Results
AI Summary
Aarey Drugs & Pharmaceuticals Ltd has announced that its Board of Directors meeting is scheduled for August 14, 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report. Additionally, the board will discuss any other matters with the Chairman's consent. In line with SEBI regulations, the company has closed its trading window from July 1, 2026, which will remain shut for 48 hours post the announcement of the financial results.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To approve unaudited financial results for Q1 FY27.
- Limited review report for Q1 FY27 to be considered.
- Trading window closed from July 1, 2026, until results announcement.
Price Impact
More from AREYDRG